A comprehensive view of Genentech Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Leaders from Genentech, Bayer, Novo Nordisk, Takeda and others to be keynote speakers at Veeva Commercial Summit; speakers to discuss strategies for effective commercialization and customer engagement
Published: April 17, 2024 by PR Newswire
Adaptimmune Therapeutics announces termination of it strategic collaboration with Genentech to develop cancer-targeted allogeneic T-cell therapies; company remains focused on launching afami-cel and developing its sarcoma franchise
Published: April 12, 2024 by Newsfile Press Release Wir
Three-year follow-up data from Phase 1 trial of BioNTech and Genentech's mRNA cancer vaccine candidate autogene cevumeran show effective T cell responses and delayed tumor recurrence in patients with resected pancreatic ductal adenocarcinoma
Published: April 07, 2024 by BioNTech SE
Lonza to acquire Genentech's large-scale biologics manufacturing plant in Vacaville, California, from Roche for US$1.2B, and invest around 500.0M Swiss francs for upgrades; the acquisition increases Lonza’s large-scale biologics manufacturing capacity
Published: March 20, 2024 by Lonza Group Ltd
Celltrion submits BLA for CT-P39, a biosimilar version of Xolair, to US FDA for treatment of multiple conditions including asthma and food allergies; submission backed by data demonstrating comparable efficacy and safety
Published: March 11, 2024 by PharmaShots

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count